Patrick Rossignol

Biography

 Patrick Rossignol, MD, PhD, is a Nephrologist and Vascular medicine specialist, Professor of Therapeutics at the University of Lorraine, France. Since 2007, he has a position of deputy Director in Nancy University Hospital Inserm Clinical Investigation Center, which is headed by Professor Faiez Zannad, researcher in Inserm UMR_S1116, and is consultant in the University Hospital Heart Failure and Hypertension Unit (ESH excellence Centre) as well as in a hemodialysis clinics within a Disease Management program. He is mainly involved in clinical research, especially concerning circulating biomarkers, in the settings of heart failure, hypertension, hemodialysis and vascular diseases. He is also involved in translational basic research studies on the mechanisms of transition of hypertension and metabolic disorders to the cardiorenal syndrome. He has been participating in 4 EU FP programs: FP-6 (Ingenious HyperCare: from hypertension to Heart Failure) and FP-7 (MEDIA: Metabolic road to DIAstolic heart Failure), EU FP7 HOMAGE (Heart failure OMics in AGEing), FIBRO-TARGETS the 2 latter coordinated by F. Zannad (CIC Nancy, France) (2013-2018) and is an EURECA-m (cardiorenal working group of ERA-EDTA) member since its creation in 2009 and got elected as board member for 6 years in 2013. He is the PI of the largest academic CV outcome RCT in hemodialysis, led in close collaboration with F-CRIN (ALCHEMIST) and steering committee member of 4 international randomized clinical trials, including one led by EURECA-m. 

Research Interest

 Nephrologist